08:00

CxO breakfast meeting: for CEOs, CFOs, COOs and CBOs active in the life sciences sector

Besides a nice and healthy breakfast new companies that started their business recently at the Leiden Bio Science Park will introduce themselves to the Life Sciences community.

Limited places are available and only to MT members from (R&D) life sciences companies who are attending the conference.

08:00

Investors forum part 1 - breakfast session -

Hosted by Johnson & Johnson Innovation

The investors forum is an exciting opportunity for those companies looking for equity capital and/or partnerships with companies and institutes across the life sciences value chain, from biotech, med tech and pharma companies to financiers and universities. The forum offers excellent opportunities for presenting your company or university to all major Dutch life sciences investors and discuss your business strategy, technology direction and capital-raising plan.

08:45

Registration and information desk open

08:45

Exhibition

Present your company, products, technology or service. Open from 08:45 till 19:30 hours.

09:30

Plenary opening programme

Hosted by Leiden Bio Science Park

• Welcome by chair
  

  Ida Haisma, Director Leiden Bio Science Park will guide us through the plenary programme.

• Opening
  

  Opening by Carmen van Vilsteren, Chair Top Sector Life Sciences & Health

  
  

• ´Novel manufacturing solutions for the rapid and cost-effective development of vaccines´
  

  by Alfred Luitjens, Global Technical Sales Director at Batavia Biosciences

  There is a constant demand for more affordable vaccines for global health (polio, measles, rubella), as well as new vaccines to protect against emerging virus outbreaks, such as Ebola, Lassa, Marburg, and coronavirus. To keep up with such demand, breakthrough technologies and global collaborations are required that allow flexible, cost-effective and rapid vaccine development. In this presentation, promising novel technologies, flexible manufacturing solutions and views on collaborations within the industry will be presented. These innovations have demonstrated to substantially lower the cost of goods and increase speed of manufacturing. Such innovations are deemed critical to stay ahead of the game and keep millions of people from dying from vaccine preventable diseases.

• ´Large scale manufacturing of CAR-T personalized medicine at BMS´
  

  by Arjen Schippers, Senior Director and Program Head at Europe Cell Therapy Facility, Bristol Myers Squibb Leiden

  Presentation on the plans of BMS for the manufacturing of current and future CAR-T therapies in the EU.
  What are CAR-T therapies, what is the best way to produce them in the EU and what are some of the challenges that you can face during startup of a new site. What are the future manufacturing scenarios for BMS.

10:50

Break

Time for networking and to visit the exhibition.

11:30

12:45

Lunch

Time for networking and to visit the exhibition.

Q&A: Funding opportunities of Top Sector Life Sciences & Health @ Health~Holland Booth
Are you in search of suitable ways to fund your innovative R&D solutions in the Life Sciences & Health (LSH) sector and are you part of a public-private partnership? Then come to the Q&A session of the Top Sector LSH and get informed. Three of our experts are happy to give you insight in the Top Sector’s funding opportunities and the terms and conditions.

13:00

Investors forum part 2 - lunch session -

Hosted by Johnson & Johnson Innovation

14:00

15:15

Break

Time for networking and to visit the exhibition.

16:00

Plenary closing programme

• Wrap up conference
  

• Announcement winner Investors Forum
  

  The winner of the Investors Forum will be awarded a partnering ticket, national or international with a total value of EUR 2,500 and will present their pitch.

• Mibiton Quality Certificate
  

  Already more than twenty-five years, dozens of young Life Sciences companies has already been able to accelerate their development, by using a Mibiton investment to purchase state-of-the art lab facilities or to produce first series of medical devices or agro-food production facilities. This year, the stem cell company Ncardia, with facilities at the Leiden Bio Science Park, was selected to receive the bi-annual “Mibiton Quality Certificate”. CEO Stefan Braam will briefly elaborate on the recent developments of his company, including the impact of both Mibiton investments.

• ´TargED Biopharmaceuticals: from Idea to Company´
  

  by Kristof Vercruysse, CEO and Co-Founder TargED Biopharmaceuticals B.V.

  TargED Biopharmaceuticals, a private biotechnology company focused on developing improved treatments for thrombotic diseases, announced recently that it has raised Series A financing of EUR 39 million to accelerate development of its lead compound, Microlyse.

  Kristof will explain what are the necessary steps to go from idea towards clinical development! What are the do’s and don’ts while setting up your company for the next steps. Building a story that is comprehensible and reproducible, a strategy that even holds in difficult therapeutic areas.

• Venture Challenge
  

  Hosted by Health~Holland

  The winners of the Venture Challenge Summer and Fall 2021 will be announced!

17:30

Reception

Drinks, bites, networking and visit the exhibition!